Latest Period
n/a
Security Snapshot
Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) Institutional Ownership
CUSIP: 03835L405
13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.30
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Common stock, par value $0.001 per share
- Symbol
- APVO on Nasdaq
- Shares outstanding
- 3,581,500
- Price per share
- $0.30
- Price from insider filings
- $0.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Quick Takeaways
- APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share is tracked under CUSIP 03835L405.
- Latest finished 13F holder period is not available.
- 3 significant owners is listed from Schedule 13D/13G reporting.
What Changed
- Holder count moved from 1 to 0 between Q2 2025 and Q3 2025.
- Reported value moved from $30,500 to $0.
Why This Matters
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Source Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Investment Quick Answers
What is CUSIP 03835L405?
CUSIP 03835L405 identifies APVO - Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Next ownership checks
Use the next link that matches the question you still need to answer about this security.
- Latest 13F filings when you want to inspect fresh institutional portfolio moves.
- Latest Schedule 13D/13G reports when you need large-owner changes outside the 13F cycle.
- All institutional ownership pages to compare this security with other holder-history pages.
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 03835L405:
Significant Owners of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Ayrton Capital LLC | 10% | $107,445 | 358,150 | Ayrton Capital LLC | 30 Jun 2025 | |||
| CVI Investments, Inc. | 6.2% | $138,000 | 200,000 | CVI Investments, Inc. | 03 Apr 2025 | |||
| Hudson Bay Capital Management LP | 5% | 0% | $52,853 | 76,598 | 0% | Hudson Bay Capital Management LP | 31 Dec 2024 |